How Does Cytisine Work in the Body

Chemical Composition, Mechanism of Action & Metabolic Effects Explained

Key Takeaways: How Cytisine Works

  • Active Ingredient: Cytisine 1.5 mg – a plant‑based alkaloid extracted from Laburnum seeds (Cytisus laburnum).
  • Primary Action: Partial agonist at α4β2 nicotinic acetylcholine receptors in the brain.
  • Clinical Effect: Reduces nicotine cravings and withdrawal symptoms, helping smokers quit.
  • Dosing Regimen: 25‑day tapering schedule; smoking must stop by day 5.
  • Metabolism: Primarily hepatic; excreted renally; half‑life approximately 4‑5 hours.

Cytisine is a nicotine‑mimetic alkaloid that helps you quit smoking by gently stimulating the same brain receptors as nicotine, curbing cravings and withdrawal without the harmful effects of tobacco. This page explains its precise pharmacological action.

Important Medical Advice

Do not use Cytisine if you are pregnant, breastfeeding, or have unstable angina, recent heart attack, stroke, or significant arrhythmia. If you experience chest pain, shortness of breath, or signs of allergic reaction, seek immediate medical help. Smoking while on Cytisine may increase side effects.

Chemical Composition & Molecular Structure

Cytisine is a tricyclic quinolizidine alkaloid naturally occurring in the seeds of Laburnum anagyroides (golden rain tree). Its chemical formula is C11H14N2O, with a molecular weight of 190.24 g/mol.

Structural Details

IUPAC Name

(1R,5S)-1,2,3,4,5,6-hexahydro-1,5-methano-8H-pyrido[1,2-a][1,5]diazocin-8-one

The molecule features a rigid bispidine core that mimics the structure of nicotine, allowing high affinity for nicotinic receptors.

Physicochemical Properties

Lipophilicity and pKa

logP ≈ 1.2; pKa ≈ 8.1 – predominantly ionised at physiological pH, yet sufficiently lipophilic to cross the blood‑brain barrier.

Formulation

Cytisine 1.5 mg tablets

Each tablet contains 1.5 mg cytisine plus excipients: mannitol, microcrystalline cellulose, magnesium stearate, glycerol dibehenate, hypromellose.

Comparison with Nicotine

PropertyCytisineNicotine
Molecular weight190.24 g/mol162.23 g/mol
Receptor affinity (α4β2)Ki ≈ 1 nMKi ≈ 1 nM
Efficacy (intrinsic activity)Partial agonist (~30%)Full agonist
Half‑life4‑5 hours2 hours

🗒️ Pharmacological insight: Cytisine’s partial agonism means it activates receptors less than nicotine, preventing the intense reward while blocking nicotine from binding – ideal for cessation.

Mechanism of Action: Nicotinic Receptor Partial Agonism

Cytisine exerts its therapeutic effect by binding to neuronal nicotinic acetylcholine receptors (nAChRs), particularly the α4β2 subtype, which is primarily responsible for nicotine dependence.

  1. Competitive binding: Cytisine competes with nicotine for the orthosteric binding site on the α4β2 receptor.
  2. Partial activation: It stabilises the receptor in a open state less frequently than nicotine, producing a sub‑maximal cation influx (mainly Ca²⁺).
  3. Dopamine modulation: In the ventral tegmental area‑nucleus accumbens pathway, this leads to a moderate, sustained dopamine release – enough to alleviate cravings and withdrawal, but without the reinforcing spike caused by smoking.
  4. Receptor desensitisation: Prolonged binding promotes receptor desensitisation, further reducing the appeal of nicotine.
FeatureCytisineNicotine
Receptor activationPartial (30‑40%)Full (100%)
Dopamine release (NAc)Moderate, stableSpiking, high
Addiction potentialVery lowHigh

🗒️ Physiological insight: Because cytisine only partially activates the receptors, it does not produce the same “reward” as nicotine, making it non‑addictive while still relieving withdrawal.

Pharmacokinetics: Absorption & Distribution

Following oral administration, cytisine is rapidly and almost completely absorbed from the gastrointestinal tract.

Absorption

Peak plasma concentrations are reached within 1‑2 hours. Bioavailability is approximately 80‑90% due to minimal first‑pass metabolism.

Distribution

Volume of distribution (Vd) ≈ 6 L/kg, indicating extensive tissue binding. It crosses the blood‑brain barrier readily and also distributes into saliva and breast milk.

Protein binding

Approximately 25% bound to plasma proteins, mainly albumin.

Systemic exposure increases proportionally with dose; steady state is reached within 2‑3 days.

Metabolic Effects & Elimination

Metabolism: Cytisine is primarily metabolised in the liver by cytochrome P450 enzymes (CYP2A6, CYP2B6, CYP2C19) to several metabolites, including N‑methylcytisine and cytisine N‑oxide, which are less active.

Elimination: Approximately 60‑70% of a dose is excreted unchanged in urine within 24 hours; the remainder as metabolites. The elimination half‑life is 4‑5 hours, allowing twice‑daily dosing in the later tapering phase.

⚠️ Metabolic caution: In patients with severe renal or hepatic impairment, cytisine accumulation may occur; use is not recommended due to lack of safety data (see PIL).

Clinical Efficacy & Dosage Schedule

The standard cytisine regimen is a 25‑day tapering schedule designed to gradually wean the brain off nicotine.

Dosing Schedule (from PIL)

DaysDosing frequencyMaximum daily dose
1‑31 tablet every 2 hours6 tablets
4‑121 tablet every 2.5 hours5 tablets
13‑161 tablet every 3 hours4 tablets
17‑201 tablet every 5 hours3 tablets
21‑251‑2 tablets per day2 tablets

Important: Smoking must stop no later than the 5th day of treatment. Continuing to smoke may increase side effects (nausea, dizziness, tachycardia). If treatment fails, a second course can be attempted after 2‑3 months.

Clinical trials show cytisine is more effective than placebo for smoking cessation, with quit rates comparable to varenicline in some head‑to‑head studies.

Cytisine FAQs

Cytisine begins to bind to nicotinic receptors within hours of the first dose, but the full reduction in cravings usually builds over the first 3‑4 days. By day 5, you should be smoke‑free.

No – you must stop smoking by day 5 at the latest. Smoking during treatment increases the risk of side effects like nausea, rapid heart rate, and blood pressure changes.

Very common side effects include dry mouth, nausea, headache, dizziness, sleep disturbances, and appetite changes. Most are mild and resolve as treatment continues.

Inform your doctor about all medicines, especially theophylline, tacrine, clozapine, and ropinirole. Avoid anti‑tuberculosis drugs. Cytisine may also reduce the effectiveness of hormonal contraceptives – use a barrier method.

No. Cytisine is contraindicated in pregnancy, breastfeeding, unstable heart conditions, recent stroke, and severe arrhythmias. It is not recommended for under‑18s, over‑65s, or those with significant kidney/liver problems.

Need Cytisine with Expert Guidance?

If you're ready to quit smoking, a UK‑registered doctor can assess your suitability for cytisine and provide a prescription.

Secure Prescription & Next-Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors

Start Smoking Cessation Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 27 February 2026

Next Review: 27 August 2026

Published on: 27 February 2026

Last Updated: 27 February 2026